SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-059508
Filing Date
2018-11-14
Accepted
2018-11-14 06:13:39
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv506085_10q.htm 10-Q 355866
2 EXHIBIT 3.1 tv506085_ex3-1.htm EX-3.1 109908
3 EXHIBIT 31.1 tv506085_ex31-1.htm EX-31.1 10591
4 EXHIBIT 31.2 tv506085_ex31-2.htm EX-31.2 10531
5 EXHIBIT 32.1 tv506085_ex32-1.htm EX-32.1 5111
  Complete submission text file 0001144204-18-059508.txt   5665388

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ampe-20180930.xml EX-101.INS 1716865
7 XBRL TAXONOMY EXTENSION SCHEMA ampe-20180930.xsd EX-101.SCH 41060
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20180930_cal.xml EX-101.CAL 20999
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20180930_def.xml EX-101.DEF 268459
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20180930_lab.xml EX-101.LAB 312341
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20180930_pre.xml EX-101.PRE 296866
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 181180200
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1